Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers

DALKILIÇ H. E. , ÖKSÜZ M. F. , tufan a. n. , özbek a., nizamoğlu a., DÖLARSLAN M. E. , ...More

European Journal of Rheumatology, vol.2, no.2, pp.62-65, 2015 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 2 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.5152/eurjrheum.2015.0101
  • Title of Journal : European Journal of Rheumatology
  • Page Numbers: pp.62-65
  • Keywords: Hepatitis B, anti-cyclic citrullinated peptide, rheumatoid factor, rheumatoid arthritis, C VIRUS-INFECTION, CCP ANTIBODIES, ARTHRITIS, CRYOGLOBULINEMIA, AUTOANTIBODIES, CLASSIFICATION, CRITERIA, ABSENCE, DISEASE, SERA


Objective: Rheumatoid factor (RF) positivity that may occur in a number of patients with hepatitis B (HBV) infection poses challenges in terms of differential diagnosis with rheumatoid arthritis (RA). On the other hand, antibodies to cyclic citrullinated peptide (anti-CCP) may prove to be an important marker for differential diagnosis of the two conditions. This study aimed to assess anti-CCP and RF positivity among patients with hepatitis B and rheumatoid arthritis.